Skin Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Skin
| Protocol | SWOG S2015 |
|---|---|
| Cancer Type: | primary cutaneous melanoma |
| Fast Facts |
Melanoma Margins Trial (MelMarT-II): A Phase III, multi-centre, multi-national randomised control trial investigating 1cm v 2cm wide excision margins for primary cutaneous melanoma
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | NRG HN014 |
|---|---|
| Cancer Type: | skin |
| Fast Facts |
NRG-HN014, Randomized Phase III Trial of Neoadjuvant Immunotherapy With Response-Adapted Treatment Versus Standard-of-Care Treatment for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
